Select Publications

Book Chapters

Gisev N; Sluggett J, 2019, 'Descriptive and Drug Utilization Studies', in Babar Z-U-D (ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy, ACADEMIC PR INC, pp. 344 - 355, http://dx.doi.org/10.1016/b978-0-128-12735-3.00027-3

Gisev N; Sluggett JK, 2019, 'Descriptive and Drug Utilization Studies', in Encyclopedia of Pharmacy Practice and Clinical Pharmacy: Volumes 1-3, pp. V2-344-V2-355, http://dx.doi.org/10.1016/B978-0-12-812735-3.00202-8

Nielsen S; Gisev N, 2017, 'Drug Pharmacology and Pharmacotherapy Treatments', in Ritter A; King T; Lee N (ed.), Drug Use and Australian Society 2nd Edition, OUP

Gisev N, 2010, 'Case 24: Neurologic and Psychotropic', in Chen T; Moles R; Basger B; Nishtala P (ed.), Case Studies in Practice: Medication Review: A Process Guide for Pharmacists

Gisev N, 2010, 'Case 25: Psychotropic, Cardiovascular, Endocrine, Respiratory, Gastrointestinal and Neurological', in Chen T; Moles R; Basger B; Nishtala P (ed.), Case Studies in Practice: Medication Review: A Process Guide for Pharmacists

Journal articles

Varney B; Zoega H; Gillies MB; Gisev N; Weston Shand A; Pearson SA; Havard A, 2024, 'Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge after Childbirth: An Australian Population-Based Cohort Study', Anesthesia and Analgesia, 138, pp. 970 - 979, http://dx.doi.org/10.1213/ANE.0000000000006582

Walpola RL; Issakhany D; Gisev N; Hopkins RE, 2024, 'The accessibility of pharmacist prescribing and impacts on medicines access: A systematic review', Research in Social and Administrative Pharmacy, 20, pp. 475 - 486, http://dx.doi.org/10.1016/j.sapharm.2024.01.006

Hopkins RE; Bharat C; Buizen L; Close J; Ivers R; Draper B; Pearson SA; Degenhardt L; Gisev N, 2024, 'Age-Related Risk of Serious Fall Events and Opioid Analgesic Use', JAMA Internal Medicine, 184, pp. 394 - 401, http://dx.doi.org/10.1001/jamainternmed.2023.8154

Koch FC; Olivier J; Brett J; Buckley NA; Gisev N; Pearson S; Daniels B, 2024, 'The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis', Medical Journal of Australia, 220, pp. 315 - 322, http://dx.doi.org/10.5694/mja2.52257

Gillies MB; Camacho X; Bharat C; Buizen L; Blyth F; Currow D; Wilson A; Degenhardt L; Gisev N; Pearson SA, 2024, 'Oxycodone initiation in Australia (2014–2018): Sociodemographic factors and preceding health service use', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16063

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L, 2024, 'Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104287

Sutherland R; Gisev N; Larney S, 2024, 'Trends in substance use and related harms among older adults in high-income countries', Addiction, http://dx.doi.org/10.1111/add.16469

Bharat C; Chidwick K; Gisev N; Farrell M; Ali R; Degenhardt L, 2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104255

Tesfaye W; Krass I; Sud K; Johnson DW; Van C; Versace VL; McMorrow R; Fethney J; Mullan J; Tran A; Robson B; Vagholkar S; Kairaitis L; Gisev N; Fathima M; Tong V; Coric N; Castelino RL, 2023, 'Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: A cluster randomised trial protocol', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-079110

Gide DN; El-Den S; Lee YLE; Gisev N; Ou K; O’Reilly CL, 2023, 'Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study', International Journal of Clinical Pharmacy, 45, pp. 1144 - 1152, http://dx.doi.org/10.1007/s11096-023-01581-1

Leung J; Chiu V; Man N; Yuen WS; Dobbins T; Dunlop A; Gisev N; Hall W; Larney S; Pearson SA; Degenhardt L; Peacock A, 2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218

Havard A; Jones N; Bharat C; Gisev N; Pearson SA; Shakeshaft A; Farrell M; Degenhardt L, 2023, 'Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality', Drug and Alcohol Review, 42, pp. 1461 - 1471, http://dx.doi.org/10.1111/dar.13669

Schaffer AL; Gisev N; Blyth FM; Buckley NA; Currow D; Dobbins TA; Wilson A; Degenhardt L; Pearson SA, 2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675

Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159

Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L, 2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310

Colledge-Frisby S; Jones N; Degenhardt L; Hickman M; Padmanathan P; Santo T; Farrell M; Gisev N, 2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851

Bharat C; Degenhardt L; Pearson SA; Buizen L; Wilson A; Dobbins T; Gisev N, 2023, 'A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data', Pharmacoepidemiology and Drug Safety, 32, pp. 352 - 365, http://dx.doi.org/10.1002/pds.5567

Santo T; Gisev N; Campbell G; Nelson E; Degenhardt L, 2023, 'The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence', Drug and Alcohol Dependence, 243, http://dx.doi.org/10.1016/j.drugalcdep.2022.109734

Lopes LC; Moga DC; Da Silva Dal Pizzol T; Gisev N; Mesgarpour B; Bérard A, 2023, 'Editorial: Women in pharmacoepidemiology: 2021', Frontiers in Pharmacology, 14, http://dx.doi.org/10.3389/fphar.2023.1278768

Gide D; El-Den S; Elim Lee YL; Gisev N; Ou K; O'Reilly C, 2023, 'Community pharmacists’ acceptability of screening for depression among older adults: A qualitative study', Research in Social and Administrative Pharmacy, 19, pp. 14 - 14, http://dx.doi.org/10.1016/j.sapharm.2023.04.041

Walpola R; Mey A; Harrison AR; Khan S; Castelino R; Gisev N, 2023, 'Evaluating informal caregivers’ needs in managing medicines for people receiving cancer treatment in Australia', Research in Social and Administrative Pharmacy, 19, pp. 5 - 5, http://dx.doi.org/10.1016/j.sapharm.2023.04.013

Hopkins RE; Degenhardt L; Campbell G; Farnbach S; Gisev N, 2022, '“Frustrated with the whole system”: a qualitative framework analysis of the issues faced by people accessing health services for chronic pain', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-08946-8

Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529

Erthal-Williamson J; Clare PJ; Gisev N; Santoso C; Berterame S, 2022, 'Trends in pharmaceutical opioid consumption in the WHO Eastern Mediterranean Region, 2010–2019', Eastern Mediterranean Health Journal, 28, pp. 788 - 797, http://dx.doi.org/10.26719/emhj.22.085

Santo T; Campbell G; Gisev N; Martino-Burke D; Wilson J; Colledge-Frisby S; Clark B; Tran LT; Degenhardt L, 2022, 'Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109551

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1954

Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N, 2022, 'Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain', International Journal of Drug Policy, 105, http://dx.doi.org/10.1016/j.drugpo.2022.103708

Hopkins RE; Campbell G; Degenhardt L; Nielsen S; Blyth F; Cohen M; Gisev N, 2022, 'Use of pharmacological and nonpharmacological treatments for chronic noncancer pain among people using opioids: a longitudinal cohort study', Pain, 163, pp. 1049 - 1059, http://dx.doi.org/10.1097/j.pain.0000000000002484

Rahman S; Trussell A; Pearson SA; Buckley NA; Karanges EA; Cairns R; Litchfield M; Todd A; Gisev N, 2022, 'Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003–2015)', Drug and Alcohol Review, 41, pp. 435 - 443, http://dx.doi.org/10.1111/dar.13391

Santo T; Campbell G; Gisev N; Degenhardt L, 2022, 'Exposure to childhood trauma increases risk of opioid use disorder among people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Dependence, 230, http://dx.doi.org/10.1016/j.drugalcdep.2021.109199

Bharat C; Larney S; Barbieri S; Dobbins T; Jones NR; Hickman M; Gisev N; Ali R; Degenhardt L, 2021, 'The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study', Addiction, 116, pp. 3139 - 3152, http://dx.doi.org/10.1111/add.15514

de Oliveira Costa J; Bruno C; Baranwal N; Gisev N; Dobbins TA; Degenhardt L; Pearson SA, 2021, 'Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019)', British Journal of Clinical Pharmacology, 87, pp. 3706 - 3720, http://dx.doi.org/10.1111/bcp.14798

Ilomaki J; Lalic S; Gisev N; Nielsen S, 2021, '1045Patterns, predictors and outcomes of opioid use in Australia: evidence for an epidemic?', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.309

Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715

Sutherland R; Jayathilake R; Peacock A; Dietze P; Bruno R; Reddel S; Gisev N, 2021, 'Trends and characteristics of extra-medical use of quetiapine among people who regularly inject drugs in Australia, 2011–2018', Drug and Alcohol Dependence, 221, http://dx.doi.org/10.1016/j.drugalcdep.2021.108636

Santo T; Campbell G; Gisev N; Tran LT; Colledge S; Di Tanna GL; Degenhardt L, 2021, 'Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108459

Gisev N; Brett J; Peacock A, 2020, 'Extra-medical use of antipsychotics: what can be learnt from experiences with other prescription medicines?', Addiction, 115, pp. 1203 - 1205, http://dx.doi.org/10.1111/add.14823

Sutherland R; Dietze PM; Gisev N; Bruno R; Campbell G; Memedovic S; Peacock A, 2020, 'Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia', Drug and Alcohol Review, 39, pp. 568 - 574, http://dx.doi.org/10.1111/dar.13083

Lalic S; Gisev N; Bell JS; Ilomäki J, 2020, 'Transition to high-dose or strong opioids: a population-based study of people initiating opioids in Australia', Addiction, 115, pp. 1088 - 1097, http://dx.doi.org/10.1111/add.14926

Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA, 2020, 'Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine', Medical Journal of Australia, 212, pp. 321 - 327, http://dx.doi.org/10.5694/mja2.50552

Santo T; Larance B; Bruno R; Gisev N; Nielsen S; Degenhardt L; Campbell G, 2020, 'Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Review, 39, pp. 128 - 134, http://dx.doi.org/10.1111/dar.13021

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009

Roxburgh A; Hall WD; Gisev N; Degenhardt L, 2019, 'Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids', Drug and Alcohol Dependence, 205, http://dx.doi.org/10.1016/j.drugalcdep.2019.06.035


Back to profile page